Szeniawska A, Jasińska B, Mazur E, Ligeza J, Fota-Markowska H, Kunkiewicz A, Niedźwiadek J
Katedra i Zaklad Mikrobiologii Lekarskiej, Akademia Medyczna w Lublinie.
Ann Univ Mariae Curie Sklodowska Med. 1992;47:127-31.
From 1986 to 1990 research was conducted on E. coli strains isolated from patients with clinical symptoms of urinary tract infection. The paper-disk-plate technique was applied to determine their susceptibility to ampicillin, carbenicillin, azlocillin, cefamandole, cefotaxime, ceftriaxone, ceftazidime, cefoperazone, amikacin, netilmicin, gentamycin, vibramycin, and colistin. According to the authors' results the efficacy of ampicillin against the examined strains is as low as 3.4%. Aminoglycosides were traditionally recommended in therapy of urinary tract infections. Our research proves amikacin and netilmicin to be more effective against E. coli than gentamycin. The third-generation cephalosporins are recommended as alternative to aminoglycosides, especially since they are proved to be non-nephrotoxic. According to the results of the authors' research ceftazidime, cefotaxime and particularly ceftriaxone show the highest activity against the used strains of E. coli.
1986年至1990年期间,对从有尿路感染临床症状的患者中分离出的大肠杆菌菌株进行了研究。采用纸碟法测定这些菌株对氨苄西林、羧苄西林、阿洛西林、头孢孟多、头孢噻肟、头孢曲松、头孢他啶、头孢哌酮、阿米卡星、奈替米星、庆大霉素、强力霉素和黏菌素的敏感性。根据作者的研究结果,氨苄西林对所检测菌株的疗效低至3.4%。传统上推荐氨基糖苷类药物用于尿路感染的治疗。我们的研究证明,阿米卡星和奈替米星对大肠杆菌的疗效比庆大霉素更好。推荐第三代头孢菌素作为氨基糖苷类药物的替代品,特别是因为已证明它们无肾毒性。根据作者的研究结果,头孢他啶、头孢噻肟,尤其是头孢曲松对所用的大肠杆菌菌株显示出最高的活性。